Viemed Healthcare (NASDAQ:VMD) Insider Sells $117,200.00 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the sale, the insider directly owned 73,214 shares of the company’s stock, valued at $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Viemed Healthcare Stock Performance

NASDAQ VMD opened at $11.63 on Monday. The business’s fifty day moving average is $9.91 and its 200-day moving average is $8.85. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.22 and a quick ratio of 1.10. The stock has a market capitalization of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $11.88.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $75.41 million for the quarter, compared to the consensus estimate of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. Equities research analysts predict that Viemed Healthcare, Inc. will post 0.44 EPS for the current year.

Institutional Trading of Viemed Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the company. State of Alaska Department of Revenue purchased a new stake in shares of Viemed Healthcare in the fourth quarter worth $25,000. Kemnay Advisory Services Inc. purchased a new position in Viemed Healthcare during the fourth quarter worth about $46,000. Quarry LP bought a new position in Viemed Healthcare in the 3rd quarter worth about $48,000. AQR Capital Management LLC bought a new position in Viemed Healthcare in the 1st quarter worth about $90,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Viemed Healthcare in the 4th quarter valued at about $101,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

Recommended Stories

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.